• Explore /
  • Poster
  • / Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) and white blood cells (WBCs) in muscle invasive and metastatic bladder cancer patients.

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) and white blood cells (WBCs) in muscle invasive and metastatic bladder cancer patients.

Abstract Poster

Authors

null

Archana Anantharaman

University of California, San Francisco, San Francisco, CA

Archana Anantharaman , Terence W. Friedlander , David Lu , Rachel Krupa , Gayatri Premasekharan , Jeffrey Hough , Matthew Edwards , Ryon Graf , Adam Jendrisak , Jessica Louw , Lyndsey Dugan , Dena C. Marrinucci , Ryan Vance Dittamore , Pamela Paris

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Urothelial Carcinoma

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 446)

DOI

10.1200/jco.2016.34.2_suppl.446

Abstract #

446

Poster Bd #

J17

Abstract Disclosures

Similar Posters

First Author: Archana Anantharaman

First Author: Terence W. Friedlander

First Author: Mathilde Cancel

Poster

2021 Gastrointestinal Cancers Symposium

Response to PD-1 and PD-L1 based immunotherapy in MSS advanced colorectal cancer is impacted by metastatic disease sites.

Response to PD-1 and PD-L1 based immunotherapy in MSS advanced colorectal cancer is impacted by metastatic disease sites.

First Author: Marwan Fakih